Stem Cell Company Stocks 11/01/09

October ended frantically as the market sold off due mostly to mutual funds locking in end of fiscal year profits. Practically every sector dropped significantly and the stem cell stocks were no exception.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- BioTime, Inc. (BTIM) = Up 26%; This pop on news that it was moving to AMEX. These stocks typically tank once they officially move. Could be a shorting opportunity

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- StemCell Inc. (STEM) = Down -29%; This stock tanked due to equity financing (A.K.A dilution). The exercise price is much higher than the current share price and the dilution is less than 10%. This looks to be a bit overdone and could be a bounce candidate.

Stem Cell Stocks Current Price and % Up or Down 10/19/09 - 10/30/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.80; Down -18%
Aastrom Biosciences (ASTM) = Cur Price: $0.32; Down -11%
BioTime, Inc. (BTIM) = Cur Price: $5.87; Up 26%
Celgene Corp (CELG) = Cur Price: $51.05; Down -10%
Cytori Therapeutics (CYTX) = Cur Price: $3.29; Down -11%
Geron Corp (GERN) = Cur Price: $6.11; Down -6%
ThermoGenesis (KOOL) = Cur Price: $0.59; Down -14%
Osiris Therapeutics (OSIR) = Cur Price: $6.35; Down -10%
StemCell Inc. (STEM) = Cur Price: $1.14; Down -29%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.113; Down -5%
Athersys Inc. (ATHX) = Cur Price: $1.17; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.31; Up 12%
Bioheart Inc. (BHRT.OB) = Cur Price: $0.91; Down -12%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.006; Unchanged
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.75; Down -18%
Neuralstem (CUR) = Cur Price: $1.27; Down -18%
International Stem Cell (ISCO.OB) = Cur Price: $0.64; Down -11%
MultiCell Technologies (MCET.OB) = Cur Price: $0.018; Down -14%
Pluristem Therapeutics (PSTI) = Cur Price: $0.98; Down -14%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.159; Down -9%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0021; Down -16%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 10/18/09

The DOW broke a 10000 last week and has been rolling along much of 2009. Most of the large cap stem cell stocks have followed the market the past two weeks, but the others have moved sporadically. The sector is still looking for a catalyst.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- ThermoGenesis (KOOL) = Up 11%; KOOL's been trading in a tight range for 8 or 9 months. It has broke out yet, but it's worth keeping an eye on it.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Bioheart Inc. (BHRT.OB) = Down -38%; This stock spiked at the beginning of September and has fallen ever since. Based on the chart, the fall isn't done.

Stem Cell Stocks Current Price and % Up or Down 10/05/09 - 10/16/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.20; Up 8%
Aastrom Biosciences (ASTM) = Cur Price: $0.36; Down -13%
BioTime, Inc. (BTIM) = Cur Price: $4.66; Down -14%
Celgene Corp (CELG) = Cur Price: $56.42; Up 4%
Cytori Therapeutics (CYTX) = Cur Price: $3.69; Up 1%
Geron Corp (GERN) = Cur Price: $6.50; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.689; Up 11%
Osiris Therapeutics (OSIR) = Cur Price: $7.03; Up 8%
StemCell Inc. (STEM) = Cur Price: $1.60; Up 3%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.119; Up 5%
Athersys Inc. (ATHX) = Cur Price: $1.16; Up 2%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.278; Down -13%
Bioheart Inc. (BHRT.OB) = Cur Price: $1.15; Down -38%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.006; Down -23%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.14; Down -3%
Neuralstem (CUR) = Cur Price: $1.54; Up 6%
International Stem Cell (ISCO.OB) = Cur Price: $0.72; Up 3%
MultiCell Technologies (MCET.OB) = Cur Price: $0.021; Down -9%
Pluristem Therapeutics (PSTI) = Cur Price: $1.14; Down -15%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.175; Down -27%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0025; Down -24%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 10/4/09

The overall market is going through a bit of a correction after an unsustainable series of up days. The stem cell stocks have been hit just like the rest of the market. There still has been no real spark in the sector.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Cord Blood America Inc. (CBAI.OB) = Up 152%; This move was caused by a combination of technicals and a series of news releases. This happens periodical with this stock. It looks like the fade has already begun.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Neurostem Inc. (CUR) = Down -22%; This stock is just retracing from a quick double a couple of weeks back. The fall happens to be just as fast the rise. Stay away.

Stem Cell Stocks Current Price and % Up or Down 9/21/09 - 10/2/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.03; Down -19%
Aastrom Biosciences (ASTM) = Cur Price: $0.414; Down -2%
BioTime, Inc. (BTIM) = Cur Price: $5.45; Up 21%
Celgene Corp (CELG) = Cur Price: $54.00; Up 3%
Cytori Therapeutics (CYTX) = Cur Price: $3.66; Up 3%
Geron Corp (GERN) = Cur Price: $6.31; Down -15%
ThermoGenesis (KOOL) = Cur Price: $0.62; Down -4%
Osiris Therapeutics (OSIR) = Cur Price: $6.53; Down -18%
StemCell Inc. (STEM) = Cur Price: $1.55; Down -11%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.113; Down -12%
Athersys Inc. (ATHX) = Cur Price: $1.14; Up 9%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.32; Up 16%
Bioheart Inc. (BHRT) = Cur Price: $1.85; Down -12%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0078; Up 152%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.20; Up 5%
Neuralstem (CUR) = Cur Price: $1.45; Down -22%
International Stem Cell (ISCO.OB) = Cur Price: $0.70; Down -19%
MultiCell Technologies (MCET.OB) = Cur Price: $0.023; Up 5%
Pluristem Therapeutics (PSTI) = Cur Price: $1.34; Up 3%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.24; Down -4%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0033; Up 18%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 9/20/09

For the most part, the stem cell stocks are still individually driven by news. However, many of the larger cap names seem to be moving higher along with the overall market. We'll see if that continues to hold true as the market inches closer to DOW 10000.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Stem Cell Therapy Intl (SCII.OB) = Up 614%; This stock spiked when the company agreed to be a party to a settlement where Histostem and Stem Cell Therapy Intl merge. This was a monstrous gain for such a small and obscure stock. It's already pulled back a lot from a high of $0.50/share, but I would still be hesitant to chase.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Osiris Therapeutics (OSIR) = Down -35%; This stock's stem cell drug failed two late stage studies and the CFO quit. Talk about a stock killer. I'd wait for this one to cool off some before I'd even consider buying.

Stem Cell Stocks Current Price and % Up or Down 9/07/09 - 9/18/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.51; Up 7%
Aastrom Biosciences (ASTM) = Cur Price: $0.424; Down -1%
BioTime, Inc. (BTIM) = Cur Price: $4.50; Up 29%
Celgene Corp (CELG) = Cur Price: $52.54; Up 2%
Cytori Therapeutics (CYTX) = Cur Price: $3.55; Up 14%
Geron Corp (GERN) = Cur Price: $7.41; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.644; Up 4%
Osiris Therapeutics (OSIR) = Cur Price: $7.97; Down -35%
StemCell Inc. (STEM) = Cur Price: $1.74; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.129; Down -17%
Athersys Inc. (ATHX) = Cur Price: $1.05; Up 7%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.275; Up 15%
Bioheart Inc. (BHRT) = Cur Price: $2.10; Up 173%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0031; Up 3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.10; Down -7%
Neuralstem (CUR) = Cur Price: $1.87; Up 64%
International Stem Cell (ISCO.OB) = Cur Price: $0.86; Up 5%
MultiCell Technologies (MCET.OB) = Cur Price: $0.022; Down -6%
Pluristem Therapeutics (PSTI) = Cur Price: $1.30; Down -1%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.25; Up 614%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0028; Down -7%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 9/6/09

The mixed bag for stem cell stocks continues. Pops seem to only occur with news on individual stocks.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Brainstorm Cell Therapeutics (BCLI) = Up 293%; A stem cell production deal cause the stock to spike. The shares hit a 52 week high of $0.38, but has dropped quickly. I'd monitor this stock after a 50% retracement to see if this is just a flash in the pan.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- MultiCell Technologies (MCET.OB) = Down -22%; This wasn't quite the biggest loser, but was the most predictable. As suggested during thr previous post, the gains didn't hold from the patent news.

Stem Cell Stocks Current Price and % Up or Down 8/24/09 - 9/4/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.35; Up 11%
Aastrom Biosciences (ASTM) = Cur Price: $0.43; Down -4%
BioTime, Inc. (BTIM) = Cur Price: $3.50; Up 13%
Celgene Corp (CELG) = Cur Price: $51.74; Down -3%
Cytori Therapeutics (CYTX) = Cur Price: $3.12; Down -3%
Geron Corp (GERN) = Cur Price: $7.21; Up 11%
ThermoGenesis (KOOL) = Cur Price: $0.62; Down -10%
Osiris Therapeutics (OSIR) = Cur Price: $12.21; Unchanged
StemCell Inc. (STEM) = Cur Price: $1.70; Up 4%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.155; Up 31%
Athersys Inc. (ATHX) = Cur Price: $0.98; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.24; Up 293%
Bioheart Inc. (BHRT) = Cur Price: $0.77; Up 28%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.003; Down -3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.25; Up 13%
Neuralstem (CUR) = Cur Price: $1.14; Up 5%
International Stem Cell (ISCO.OB) = Cur Price: $0.82; Unchanged
MultiCell Technologies (MCET.OB) = Cur Price: $0.0235; Down -22%
Pluristem Therapeutics (PSTI) = Cur Price: $1.31; Down -10%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.035; Down -27%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.003; Down -6%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 8/23/09

The Dow is currently at 9500 and everything is moving higher except the stem cell stocks. Even star performers like GERN are CYTX have turned south. This sector is in major need of a catalyst.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- MultiCell Technologies (MCET.OB) = Up 233%; This one spiked on a patent approval. Most traders know this stock has a very tight float and typically makes big moves when it does move. The gains never hold, so don't jump in late.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

- Bioheart Inc. (BHRT.OB) = Down -27%; The stock dropped for no particular reason and it's currently sitting around its 52 week low. This is potentially a good bounce play, but be careful with the low volume.

Stem Cell Stocks Current Price and % Up or Down 8/10/09 - 8/21/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $2.12; Up 12%
Aastrom Biosciences (ASTM) = Cur Price: $0.45; Up 2%
BioTime, Inc. (BTIM) = Cur Price: $3.10; Down -12%
Celgene Corp (CELG) = Cur Price: $53.15; Down -3%
Cytori Therapeutics (CYTX) = Cur Price: $3.20; Unchanged
Geron Corp (GERN) = Cur Price: $6.52; Down -15%
ThermoGenesis (KOOL) = Cur Price: $0.69; Unchanged
Osiris Therapeutics (OSIR) = Cur Price: $12.25; Up 7%
StemCell Inc. (STEM) = Cur Price: $1.63; Down -1%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.118; Down -19%
Athersys Inc. (ATHX) = Cur Price: $0.97; Down -5%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.061; Down -13%
Bioheart Inc. (BHRT) = Cur Price: $0.60; Down -27%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0031; Down -3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $2.00; Up 18%
Neuralstem (CUR) = Cur Price: $1.09; Down -11%
International Stem Cell (ISCO.OB) = Cur Price: $0.82; Down -7%
MultiCell Technologies (MCET.OB) = Cur Price: $0.03; Up 233%
Pluristem Therapeutics (PSTI) = Cur Price: $1.45; Up 4%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.048; Up 7%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0032; Up 14%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 8/08/09

The stock market isn't letting up but the stem cell stock trade is practically dead. GERN and CYTX have been solid performers as large caps during the overall market's run. However, the small caps have done basically nothing as a whole. We'll continue to monitor them all.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Brainstorm Cell Therapeutics (BCLI.OB) = Up 37%; This was one of the worst performers two weeks ago. This is typical penny stock action. I wouldn't read too much into this one.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

-Osiris Therapeutics (OSIR) = Down -10%; This stock is hovering around its 52 week low. Keep an eye out for this one. It may be due for a bounce.

Stem Cell Stocks Current Price and % Up or Down 7/27/09 - 8/7/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.89; Up 9%
Aastrom Biosciences (ASTM) = Cur Price: $0.44; Up 13%
BioTime, Inc. (BTIM) = Cur Price: $3.53; Up 9%
Celgene Corp (CELG) = Cur Price: $55.05; Up 1%
Cytori Therapeutics (CYTX) = Cur Price: $3.21; Down -5%
Geron Corp (GERN) = Cur Price: $7.63; Down -5%
ThermoGenesis (KOOL) = Cur Price: $0.69; Up 3%
Osiris Therapeutics (OSIR) = Cur Price: $11.44; Down -10%
StemCell Inc. (STEM) = Cur Price: $1.64; Down -2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.145; Down -11%
Athersys Inc. (ATHX) = Cur Price: $1.02; Up 15%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Up 37%
Bioheart Inc. (BHRT) = Cur Price: $0.82; Up 11%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0032; Down -6%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.70; Down -4%
Neuralstem (CUR) = Cur Price: $1.22; Up 14%
International Stem Cell (ISCO.OB) = Cur Price: $0.88; Down -3%
MultiCell Technologies (MCET.OB) = Cur Price: $0.009; Up 18%
Pluristem Therapeutics (PSTI) = Cur Price: $1.39; Down -3%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.045; Down -10%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.0028; Down -7%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Company Stocks 7/26/09

As expected, the market has exploded higher thanks to improved earnings from a large percentage of reporting companies. Even the stem cell stocks are being pushed up. The larger cap stocks in the sector seem to be performing the strongest. It'll be interesting to see if this trend continues.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Cryo-Cell International (CCEL.OB) = Up 25%; After a slight retracement from positive earnings report, this stock has resumed it's upward climb.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

-MultiCell Technologies Inc. (MCET.OB) = Down -31%; There has been no news from the company. The stock is acting like a typical penny stock. It's heading back down to it's 52 week low. I would even consider this one until it gets there.

Stem Cell Stocks Current Price and % Up or Down 7/13/09 - 7/24/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.73; Up 12%
Aastrom Biosciences (ASTM) = Cur Price: $0.388; Up 3%
BioTime, Inc. (BTIM) = Cur Price: $3.25; Down -1%

Celgene Corp (CELG) = Cur Price: $54.64; Up 19%
Cytori Therapeutics (CYTX) = Cur Price: $3.39; Up 7%
Geron Corp (GERN) = Cur Price: $7.99; Up 9%
ThermoGenesis (KOOL) = Cur Price: $0.67; Up 19%
Osiris Therapeutics (OSIR) = Cur Price: $12.76; Up 11%
StemCell Inc. (STEM) = Cur Price: $1.67; Up 6%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.163; Up 1%
Athersys Inc. (ATHX) = Cur Price: $0.89; Up 11%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.051; Down -27%
Bioheart Inc. (BHRT) = Cur Price: $0.74; Up 6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0034; Up 3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.77; Up 25%
Neuralstem (CUR) = Cur Price: $1.07; Down -6%
International Stem Cell (ISCO.OB) = Cur Price: $0.91; Up 5%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0076; Down -31%
Pluristem Therapeutics (PSTI) = Cur Price: $1.43; Up 11%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.05; Unchanged
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.003; Unchanged

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key.

Stem Cell Stocks 7/12/09: The Past Two Weeks

The overall market is continuing its slide. Most people are waiting to see how it responds at key technical points of 850 on the S&P and 8000 on the DOW. Meanwhile, i've been interested to see how the stem cell stocks perform. It was one of the few sectors that performed well when market initially tanked at the end of 2008. However, overall there hasn't been a repeat performance.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- BioTime Inc. (BTIM.OB) = Up 37%; A stem cell marketing agreement was announce by Biotime with Millipore. The price rose on 5 times the average daily volume. This stock has a history of spiking then falling quickly. I wouldn't recommend chasing.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

-Advanced Cell Technology (ACTC.OB) = Down -36%; After a huge move 2 weeks ago, ACTC.OB was unable to break out of that 25-30 cents range. Once it failed, it made for a great short opportunity. It's hard to say when the freefall will end.

Stem Cell Stocks Current Price and % Up or Down 6/29/09 - 7/10/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.54; Down -7%
Aastrom Biosciences (ASTM) = Cur Price: $0.375; Down -6%
BioTime, Inc. (BTIM.OB) = Cur Price: $3.28; Up 37%
Celgene Corp (CELG) = Cur Price: $46.10; Down -4%
Cytori Therapeutics (CYTX) = Cur Price: $3.18; Down -19%
Geron Corp (GERN) = Cur Price: $7.32; Up 5%
ThermoGenesis (KOOL) = Cur Price: $0.565; Down-9%
Osiris Therapeutics (OSIR) = Cur Price: $11.53; Down -13%
StemCell Inc. (STEM) = Cur Price: $1.57; Down -13%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.162; Down -36%
Athersys Inc. (ATHX) = Cur Price: $0.80; Down -4%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0695; Down -1%
Bioheart Inc. (BHRT) = Cur Price: $0.70; Down -18%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0033; Down -13%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.42; Up 23%
Neuralstem (CUR) = Cur Price: $1.14; Down -5%
International Stem Cell (ISCO.OB) = Cur Price: $0.87; Up 9%
MultiCell Technologies (MCET.OB) = Cur Price: $0.011; Up 5%
Pluristem Therapeutics (PSTI) = Cur Price: $1.29; Up 2%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.05; Unchanged
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.03; Down -17%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.

Stem Cell Stocks 6/27/09: The Past Two Weeks

Because of the stagnant nature in which the stem cell stocks have been performing the last few months, I've decide to adjust my posting intervals to every two weeks. Once again, select names have been performing steadily, but overall nothing special has occurred in the sector.

Top Stem Cell Stock Performer(s) the Last Two Weeks:

- Advanced Cell Technology (ACT.OB) = Up 51%; There's been no real news, but the stock's been on a technical tear. If it breaks out of the 25-30 cent range, it could double.

Worst Stem Cell Stock Performer(s) the Last Two Weeks:

-ThermoGenesis Corp. (KOOL) = Down -15%; After a 50% spike up a few weeks ago, this stock has come crashing back down to earth. It looks like it needs news to move higher.

Stem Cell Stocks Current Price and % Up or Down 6/15/09 - 6/26/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.66; Down -11%
Aastrom Biosciences (ASTM) = Cur Price: $0.40; Up 14%
BioTime, Inc. (BTIM) = Cur Price: $2.40; Down -9%
Celgene Corp (CELG) = Cur Price: $48.03; Up 11%
Cytori Therapeutics (CYTX) = Cur Price: $3.95; Down -2%
Geron Corp (GERN) = Cur Price: $6.95; Up 1%
ThermoGenesis (KOOL) = Cur Price: $0.62; Down-15%
Osiris Therapeutics (OSIR) = Cur Price: $13.25; Down -5%
StemCell Inc. (STEM) = Cur Price: $1.80; Up 8%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.252; Up 51%
Athersys Inc. (ATHX) = Cur Price: $0.83; Down -12%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Down -6%
Bioheart Inc. (BHRT) = Cur Price: $0.85; Up 1%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0038; Down -7%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.15; Down -4%
Neuralstem (CUR) = Cur Price: $1.20; Up 10%
International Stem Cell (ISCO.OB) = Cur Price: $0.80; Down-13%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0105; Down -19%
Pluristem Therapeutics (PSTI) = Cur Price: $1.27; Down -5%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.05; Down -9%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.036; Down -5%

Catalyst(s):

Still, nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.

Stem Cell Stocks 6/14/09: The Week That Was

It appears that the moved in the stem cell stocks two weeks ago was nothing more the a blip on the radar. Last week was much of the same mixed bag action we've seen the past 3 or 4 months. I believe these stocks are still waiting for a catalyst to break through.

Top Stem Cell Stock Performer(s) for Last Week:

None

Worst Stem Cell Stock Performer(s) for Last Week:

-Stem Cell Innovations (SCLL.OB) = Down -21%; This stock has been getting killed since its brief run in February. There has been no news, just continued downward pressure.

Stem Cell Stocks Current Price and % Up or Down 6/8/09 - 6/12/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.86; Up 12%
Aastrom Biosciences (ASTM) = Cur Price: $0.351; Down -3%
BioTime, Inc. (BTIM) = Cur Price: $2.63; Down -6%
Celgene Corp (CELG) = Cur Price: $43.23; Down -3%
Cytori Therapeutics (CYTX) = Cur Price: $4.04; Down -8%
Geron Corp (GERN) = Cur Price: $6.85; Unchanged
ThermoGenesis (KOOL) = Cur Price: $0.73; Unchanged
Osiris Therapeutics (OSIR) = Cur Price: $13.91; Down -1%
StemCell Inc. (STEM) = Cur Price: $1.66; Down -5%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.167; Up 8%
Athersys Inc. (ATHX) = Cur Price: $0.94; Up 5%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0748; Up 3%
Bioheart Inc. (BHRT) = Cur Price: $0.84; Up 6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0041; Up 3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.20; Down -4%
Neuralstem (CUR) = Cur Price: $1.09; Down -8%
International Stem Cell (ISCO.OB) = Cur Price: $0.92; Up 1%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0129; Down -13%
Pluristem Therapeutics (PSTI) = Cur Price: $1.33; Up 5%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.055; Up 12%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.038; Down -21%

Catalyst(s):

Nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.

Stem Cell Stocks 6/07/09: The Week That Was

Mark this week's post as the start of a possible stem cell stock turnaround. For the first time since January, every larger cap stem cell stock that we follow finished the week in positive territory. The sector has not done much in last three months with the exception of moves the last month by Geron and Cytori Therapeutics. There has been no notable catalyst that has caused this shift in activity. As a result, a follow up week will be big in determining if the stem cell stocks have new life.

Top Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis Corp (KOOL) = Up 38% for the week; Volume jumped significantly in KOOL during later part of the week. Either news is coming or institutions have begun to buy

Worst Stem Cell Stock Performer(s) for Last Week:

-Stem Cell Therapy Intl (SCII.OB) = Down -18; This stock has been in free fall from $0.12/share since April. Based on the chart, I wouldn't consider buying this until it hits $0.02 a share



Stem Cell Stocks Current Price and % Up or Down 6/1/09 - 6/5/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.66; Up 11%
Aastrom Biosciences (ASTM) = Cur Price: $0.361; Up 8%
BioTime, Inc. (BTIM) = Cur Price: $2.80; Up 10%
Celgene Corp (CELG) = Cur Price: $44.35; Up 5%
Cytori Therapeutics (CYTX) = Cur Price: $4.37; Up 15%
Geron Corp (GERN) = Cur Price: $6.83; Up 5%
ThermoGenesis (KOOL) = Cur Price: $0.73; Up 38%
Osiris Therapeutics (OSIR) = Cur Price: $14.11; Up 12%
StemCell Inc. (STEM) = Cur Price: $1.75; Up 7%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.155; Up 5%
Athersys Inc. (ATHX) = Cur Price: $0.899; Up 7%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0725; Up 4%
Bioheart Inc. (BHRT) = Cur Price: $0.79; Down -6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.004; Down -2%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.25; Unchanged
Neuralstem (CUR) = Cur Price: $1.19; Up 13%
International Stem Cell (ISCO.OB) = Cur Price: $0.91; Down -9%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0149; Down -10%
Pluristem Therapeutics (PSTI) = Cur Price: $1.27; Up 2%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.049; Down -18%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.048; Unchanged

Catalyst(s):


Nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves

Stem Cell Stocks 5/31/09: The Week That Was

Last week consisted of more sporadic trading for the stem cell stocks. I'm still trying to figure out if there is some correlation between the general market and the stem cell sector, but as of right now, nothing stands out.

Top Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Up 47% for the week; Mid-week ISCO.OB received positive early results from animal trials designed to improve photorefractive keratectomy (PRK), a form of corrective laser eye surgery that offers an improved alternative to LASIK.

Worst Stem Cell Stock Performer(s) for Last Week:

Cord Blood America Inc. (CBAI.OB) = Down -15%; This stock was flat all week and then tanked the last hour of the last trading day of the week. It looks like frustrated traders are throwing in the towel.

Stem Cell Stocks Current Price and % Up or Down 5/25/09 - 5/29/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.50; Up 8%
Aastrom Biosciences (ASTM) = Cur Price: $0.335; Down -7%
BioTime, Inc. (BTIM) = Cur Price: $2.55; Down -3%
Celgene Corp (CELG) = Cur Price: $42.24; Up 7%
Cytori Therapeutics (CYTX) = Cur Price: $3.79; Up 32%
Geron Corp (GERN) = Cur Price: $6.52; Down -4%
ThermoGenesis (KOOL) = Cur Price: $0.53; Down -4%
Osiris Therapeutics (OSIR) = Cur Price: $12.61; Up 5%
StemCell Inc. (STEM) = Cur Price: $1.63; Down -3%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.148; Up 14%
Athersys Inc. (ATHX) = Cur Price: $0.84; Down -6%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Down -8%
Bioheart Inc. (BHRT) = Cur Price: $0.84; Down -7%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0041; Down -15%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.25; Up 9%
Neuralstem (CUR) = Cur Price: $1.05; Down -5%
International Stem Cell (ISCO.OB) = Cur Price: $1.00; Up 47%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0165; Up 38%
Pluristem Therapeutics (PSTI) = Cur Price: $1.24; Up 7%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.06; Down -8%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.048; Down -4%

Catalyst(s):

Nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.

Stem Cell Stocks 5/24/09: The Week That Was

It was flat week for the most part for the stem cell stocks. Overall, the stocks that have fallen the hardest in the sector have finally begun to level out. As a result, now may finally be the time to consider buying select names in the sector. The only stem cell stock that has shown consistent upward movement over the last 3 months has been Geron Corp. (GERN).







Top Stem Cell Stock Performer(s) for Last Week:

- Bioheart Inc. (BHRT.OB) = Up 38%; The low volume continues to yield wild swings. If you recall, Bioheart was the worst performer of the group the previous week.



Worst Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Down -22% for the week; With ISCO.OB being the best performer the previous week, we mentioned that it would be a good stock to short due to profit taking. It looks like we were right.

Stem Cell Stocks Current Price and % Up or Down 5/18/09 - 5/22/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.39; Unchanged
Aastrom Biosciences (ASTM) = Cur Price: $0.36; Down -3%
BioTime, Inc. (BTIM) = Cur Price: $2.64; Up 2%
Celgene Corp (CELG) = Cur Price: $39.43; Down -1%
Cytori Therapeutics (CYTX) = Cur Price: $2.88; Up 3%
Geron Corp (GERN) = Cur Price: $6.79; Up 8%
ThermoGenesis (KOOL) = Cur Price: $0.553; Down -3%
Osiris Therapeutics (OSIR) = Cur Price: $12.02; Down -3%
StemCell Inc. (STEM) = Cur Price: $1.68; Down -4%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.13; Down -7%
Athersys Inc. (ATHX) = Cur Price: $0.89; Up 9%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.076; Down -5%
Bioheart Inc. (BHRT) = Cur Price: $0.90; Up 38%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0048; Down -13%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.15; Down -4%
Neuralstem (CUR) = Cur Price: $1.10; Down -7%
International Stem Cell (ISCO.OB) = Cur Price: $0.68; Down -22%
MultiCell Technologies (MCET.OB) = Cur Price: $0.012; Up 14%
Pluristem Therapeutics (PSTI) = Cur Price: $1.16; Down -19%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.065; Unchanged
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.05; Up 2%

Catalyst(s) for the Week:

Nothing has changed from the last few months.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 5/17/09: The Week That Was

If you remember back to when the market was in its tailspin, one of the only plays that seemed to work were the stem cell stocks. With the overall market currently in a bit of a slide, it was interesting to see if the sector would again be a strong performer. However, nothing much has changed. The only upward movement has come from those individual stocks with news or out of the blue trading momentum.

Top Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Up 98% for the week; This stock acted very unusual last week. At one point the stock nearly tripled. Shares spiked on 8 times the average volume on four consecutive trading days. Friday it finally pulled back. All this movement occurred with no news. It looks like a huge short opportunity if you're into that.

Worst Stem Cell Stock Performer(s) for Last Week:

- Bioheart Inc. (BHRT.OB) = Down -24%; Stock has very low volume. Swings of this sort are not uncommon

Stem Cell Stocks Current Price and % Up or Down 5/11/09 - 5/15/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.39; Up 5%
Aastrom Biosciences (ASTM) = Cur Price: $0.37; Down -6%
BioTime, Inc. (BTIM) = Cur Price: $2.60; Up 37%
Celgene Corp (CELG) = Cur Price: $39.79; Down -4%
Cytori Therapeutics (CYTX) = Cur Price: $2.80; Up 12%
Geron Corp (GERN) = Cur Price: $6.26; Up 1%
ThermoGenesis (KOOL) = Cur Price: $0.57; Up 6%
Osiris Therapeutics (OSIR) = Cur Price: $12.35; Down -7%
StemCell Inc. (STEM) = Cur Price: $1.75; Up 3%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.14; Up 43%
Athersys Inc. (ATHX) = Cur Price: $0.82; Unchanged
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.08; Up 14%
Bioheart Inc. (BHRT) = Cur Price: $0.65; Down -24%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0055; Down -4%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.20; Down -15%
Neuralstem (CUR) = Cur Price: $1.18; Down -2%
International Stem Cell (ISCO.OB) = Cur Price: $0.87; Up 98%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0105; Up 4%
Pluristem Therapeutics (PSTI) = Cur Price: $1.44; Up 9%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.065; Down -4%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.049; Up 26%

Catalyst(s) for the Week:

Nothing has changed from the last few months.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 5/10/09: The Week That Was

Only individual names in the stem cell sector moved this week. Names like GERN and CCEL have impressive charts over the last month, but we have still yet to see that large group move like earlier in the year. Look for there to be continued sporadic movement in the sector.

Top Stem Cell Stock Performer(s) for Last Week:

- Cytori Therapeutics (CYTX) = Up 37% for the week; They announced an agreement by which GE Healthcare will commercialize Cytori’s StemSource® technology in the North American stem cell banking and research markets.

Worst Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis Corp (KOOL) = Down -19%; Got hammered for reporting 2009 revenue outlook below analyst estimates.

Stem Cell Stocks Current Price and % Up or Down 5/4/09 - 5/8/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.32; Down -11%
Aastrom Biosciences (ASTM) = Cur Price: $0.394; Up 4%
BioTime, Inc. (BTIM) = Cur Price: $1.90; Down -2%
Celgene Corp (CELG) = Cur Price: $41.42; Up 5%
Cytori Therapeutics (CYTX) = Cur Price: $2.50; Up 37%
Geron Corp (GERN) = Cur Price: $6.23; Up 22%
ThermoGenesis (KOOL) = Cur Price: $0.54; Down -19%
Osiris Therapeutics (OSIR) = Cur Price: $13.35; Up 7%
StemCell Inc. (STEM) = Cur Price: $1.70; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.098; Down -1%
Athersys Inc. (ATHX) = Cur Price: $0.82; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Down -5%
Bioheart Inc. (BHRT) = Cur Price: $0.85; Up 9%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0057; Up 6%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.42; Up 15%
Neuralstem (CUR) = Cur Price: $1.21; Up 5%
International Stem Cell (ISCO.OB) = Cur Price: $0.44; Down -6%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0101; Down -8%
Pluristem Therapeutics (PSTI) = Cur Price: $1.32; Down -13%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.068; Down -9%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.039; Unchanged

Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 5/3/09: The Week That Was

As expected, the stem cell stocks still did not move this week. A couple of stocks with connections to cancer or the flu moved early in the week, but gave up their gains. Look for there to be continued sporadic movement in the sector.

Top Stem Cell Stock Performer(s) for Last Week:

- Cryo-Cell International (CCEL) = Up 54% for the week; This stock stock has more than doubled in the last 2 1/2 weeks. The rise is began shortly after an earnings report that pointed to a bright future. Look for a pull back shortly.

Worst Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy Intl (SCII) = Down -21% for the week on average volume; No significant news; not out of the ordinary for a penny stock

Stem Cell Stocks Current Price and % Up or Down 4/27/09 - 5/01/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.49; Down -2%
Aastrom Biosciences (ASTM) = Cur Price: $0.38; Up 17%
BioTime, Inc. (BTIM) = Cur Price: $1.94; Down -11%
Celgene Corp (CELG) = Cur Price: $39.54; Down -1%
Cytori Therapeutics (CYTX) = Cur Price: $1.82; Up 2%
Geron Corp (GERN) = Cur Price: $5.10; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.67; Up 14%
Osiris Therapeutics (OSIR) = Cur Price: $12.42; Up 1%
StemCell Inc. (STEM) = Cur Price: $1.66; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.099; Down -1%
Athersys Inc. (ATHX) = Cur Price: $0.81; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.074; Down -8%
Bioheart Inc. (BHRT) = Cur Price: $0.78; Up 13%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0054; Down -2%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.23; Up 54%
Neuralstem (CUR) = Cur Price: $1.15; Down -3%
International Stem Cell (ISCO.OB) = Cur Price: $0.47; Down -10%
MultiCell Technologies (MCET.OB) = Cur Price: $0.011; Up 10%
Pluristem Therapeutics (PSTI) = Cur Price: $1.52; Up 14%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.075; Down -21%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.039; Down -5%

Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 4/26/09: The Week That Was

There has still been no signifcant action with the stem cell stocks. Cancer drugs were hot last week. This week, it's all about the swine flu. As a result, I don't anticipate much upward movement with these stocks this week.

Top Stem Cell Stock Performer(s) for Last Week:

- BioTime, Inc. (BTIM) = Up 25% for the week; This stock rose on word that Broadwood Partners, which is already one of BTIM's large share holders, purchased around 35,000 additional shares.

Worst Stem Cell Stock Performer(s) for Last Week:

- Geron Corp (GERN) = Down -9% for the week; No signicant news; The stock had been on a good run the past few weeks. This just looks like profit taking.

Stem Cell Stocks Current Price and % Up or Down 4/20/09 - 4/24/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.52; Up 3%
Aastrom Biosciences (ASTM) = Cur Price: $0.326; Down -8%
BioTime, Inc. (BTIM) = Cur Price: $2.17; Up 24%
Celgene Corp (CELG) = Cur Price: $39.86; Up 4%
Cytori Therapeutics (CYTX) = Cur Price: $1.79; Down -1%
Geron Corp (GERN) = Cur Price: $4.94; Down -9%
ThermoGenesis (KOOL) = Cur Price: $0.59; Down -4%
Osiris Therapeutics (OSIR) = Cur Price: $12.34; Down -4%
StemCell Inc. (STEM) = Cur Price: $1.62; Down -4%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.0995; Unchanged
Athersys Inc. (ATHX) = Cur Price: $0.80; Down -1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.08; Unchanged
Bioheart Inc. (BHRT) = Cur Price: $0.69; Unchanged
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0057; Down -4%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $0.80; Up 14%
Neuralstem (CUR) = Cur Price: $1.18; Down -2%
International Stem Cell (ISCO.OB) = Cur Price: $0.525; Up 22%
LifeStem International (LSTM.OB) = Cur Price: $0.008; Down -11%
MultiCell Technologies (MCET.OB) = Cur Price: $0.01; Down -5%
Pluristem Therapeutics (PSTI) = Cur Price: $1.33; Unchanged
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.095; Down -5%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.041; Up 3%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 4/19/09: The Week That Was

Once again nothing definitive this week for the stem cell stocks. Most the the larger cap stock were up, but most of the smaller cap stocks fell for the week. I am really not expecting much from the stem cells stocks in the very near future. With the news from Dendreon last week, cancer related biotech stocks have become the new hot play. Unless some fresh big news develops in the stem cell space, look for the current trading action to continue.


Top Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis (KOOL) = Up 19% for the week; The only real news this week was that they appointed a new CEO; I don't think that is enough to maintain this momentum

Worst Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Down -14% for the week; No news; A couple of weeks ago this had one of the best charts in the sector. It has significantly brokend down since then

Stem Cell Stocks Current Price and % Up or Down 4/13/09 - 4/17/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.48; Up 3%
Aastrom Biosciences (ASTM) = Current Price: $0.354; Up 4%
BioTime, Inc. (BTIM) = Current Price: $1.75; Down -9%
Celgene Corp (CELG) = Current Price: $38.30; Down -6%
Cytori Therapeutics (CYTX) = Current Price: $1.81; Up 5%
Geron Corp (GERN) = Current Price: $5.40; Up 10%
ThermoGenesis (KOOL) = Current Price: $0.615; Up 19%
Osiris Therapeutics (OSIR) = Current Price: $12.82; Up 3%
StemCell Inc. (STEM) = Current Price: $1.69; Up 8%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.0995; Up 2%
Athersys Inc. (ATHX) = Current Price: $0.81; Down -4%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.08; Down -10%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.69; Up 1%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0057; Unchanged
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.70; Unchanged
Neuralstem (CUR) = Current Price: $1.20; Down -2%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.43; Down -14%
LifeStem International (LSTM.OB) = Current Price: $0.009; Down -2%
MultiCell Technologies (MCET.OB) = Current Price: $0.0105; Down -10%
Pluristem Therapeutics (PSTI) = Current Price: $1.33; Up 8%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.10; Unchanged
Stem Cell Innovations (SCLL.PK) = Current Price: $0.04; Down -13%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

While the stem cell stocks lag, don't forget to check out my other blog http://yourtradingtips.blogspot.com which provides some insight on ways to make some quick money in the stock market.

Stem Cell Stocks 4/11/09: The Week That Was

The stem cell stocks were a mixed bag this week. They still seem to be in search of that key news to put the sector back in the spotlight. Overall, the stock market was flat during the week and the stem cell stocks seemed to follow suit. However, I have noticed over the past few weeks that those stem cell stocks that have reported quarterly earnings have responded positively (albeit temporarily).

Top Stem Cell Stock Performer(s) for Last Week:

- Cyro-Cell International (CCEL.OB) = Up 37% for the week; On 4/9/09 CCEL reported Qtr.1 2009 results; The most notable news was that the company stated that prospective clients were up 94% compared to the same period a year ago.



Worst Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy International Inc. (SCII.OB) = Down; -20% for the week; Last week this was the sector's top gainer; It looks like this is just classic profit taking


Stem Cell Stocks Current Price and % Up or Down 4/06/09 - 4/10/09


Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.43; Up 6%
Aastrom Biosciences (ASTM) = Current Price: $0.34; Down -7%
BioTime, Inc. (BTIM) = Current Price: $1.93; Down -9%
Celgene Corp (CELG) = Current Price: $40.80; Down -3%
Cytori Therapeutics (CYTX) = Current Price: $1.72; Down -5%
Geron Corp (GERN) = Current Price: $4.92; Up 9%
ThermoGenesis (KOOL) = Current Price: $0.518; Down -9%
Osiris Therapeutics (OSIR) = Current Price: $12.42; Down -9%
StemCell Inc. (STEM) = Current Price: $1.57; Down -5%

Market Cap Under 50 Million


Advanced Cell Technology (ACTC.OB) = Current Price: $0.098; Down -7%
Athersys Inc. (ATHX) = Current Price: $0.84; Up 5%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.089; Up 5%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.68; Up 24%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0057; Down -14%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.70; Up 37%
Neuralstem (CUR) = Current Price: $1.23; Down -3%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.50; Up 2%
LifeStem International (LSTM.OB) = Current Price: $0.0092; Down -8%
MultiCell Technologies (MCET.OB) = Current Price: $0.0117; Down -6%
Pluristem Therapeutics (PSTI) = Current Price: $1.23; Down -1%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.10; Down -20%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.046; Down -8%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 4/3/09: The Week That Was

This was another lackluster week for the stem cell stocks. Most of these stocks were slightly down, while once again, the overall market edged higher. In an incredible sign of market strength, the the Dow closed the week over 8000. The stem cell stocks are still not participating in the rally.

Top Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy International Inc. (SCII.OB) = Up 67% for the week; Last week the company announced its first new product, a cosmetic face cream made with stem cells. The cream is said to rejuvenate the skin and provide excellent health for facial tissues. The market seemed to be impressed.

Worst Stem Cell Stock Performer(s) for Last Week

- Cord Blood America (CBAI.OB) = Down -23% for the week; After a brief rise, the stock appears to be under selling pressure after it was voted to allow management to increase the number authorized common shares.

Stem Cell Stocks Current Price and % Up or Down 3/30/09 - 4/03/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.35; Down -1%
Aastrom Biosciences (ASTM) = Current Price: $0.365; Down -9%
BioTime, Inc. (BTIM) = Current Price: $2.11; Unchanged
Celgene Corp (CELG) = Current Price: $42.15; Down -8%
Cytori Therapeutics (CYTX) = Current Price: $1.81; Up 1%
Geron Corp (GERN) = Current Price: $4.51; Down -8%
ThermoGenesis (KOOL) = Current Price: $0.57; Down -5%
Osiris Therapeutics (OSIR) = Current Price: $13.66; Down -5%
StemCell Inc. (STEM) = Current Price: $1.66; Down -8%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.105; Down -16%
Athersys Inc. (ATHX) = Current Price: $0.80; Down -8%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.085; Down -8%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.55; Down -8%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0066; Down -23%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.512; Down -17%
Neuralstem (CUR) = Current Price: $1.27; Up 20%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.49; Down -2%
LifeStem International (LSTM.OB) = Current Price: $0.01; Up 33%
MultiCell Technologies (MCET.OB) = Current Price: $0.0125; Down -7%
Pluristem Therapeutics (PSTI) = Current Price: $1.24; Down -8%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.125; Up 67%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.005; Down -17%

Possible Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Ending Thoughts:

The stem cell stocks definitely need to get moving in the next couple of weeks to maintain any level of relevancy. With the market bulling its way forward and so many other sectors recovering with such strength, these stocks are in desperate need of a charge.

Stem Cell Stocks 3/28/09: The Week That Was

This was a nice bounce back week for the stem cell stocks. For a quite a bit of time, it appeared that the market had forgotten this entire sector, but things finally seemed to take a turn for the better. Nothing really earth shattering happened to cause the change in sentiment. As result, I can only conclude that it was the stem cell stocks' turn to catch up.

I recently decided to make a modification to this blog. Because many of the stem cell stocks have technically detached from the previous pivot point of 1/23/09, I've decided to now track each stock based on their weekly performance.

Top Stem Cell Stock Performer(s) for Last Week:

- Advanced Cell Technology (ACTC.OB) = Up 67% for the week; If you remember, ACTC.OB was the worst performer last week. This week there was no major news, but as I figured, it bounced right back.

Worst Stem Cell Stock Performer(s) for Last Week:

- Osiris Therapeutics (OSIR) = Down -21% for the week; This tanked due to the company discontinuing a phase III Crohn's Disease trial.


- Stem Cell Innovations (SCLL.PK) = Down -20% for the week; Another one of those stocks significantly beaten in the stem cell sector the past 3 weeks on no news. It seems to be following a similar trend as ACTC.OB. I eventually think this trend should reverse.


Stem Cell Stocks Current Price and % Up or Down 3/23/09 - 3/27/09


Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.36; Up 9%
Aastrom Biosciences (ASTM) = Current Price: $0.40; Up 14%
BioTime, Inc. (BTIM) = Current Price: $2.10; Up 2%
Celgene Corp (CELG) = Current Price: $46.04; Up 1%
Cytori Therapeutics (CYTX) = Current Price: $1.80; Up 5%
Geron Corp (GERN) = Current Price: $4.89; Up 20%
ThermoGenesis (KOOL) = Current Price: $0.60; Up 18%
Osiris Therapeutics (OSIR) = Current Price: $14.32; Down -21%
StemCell Inc. (STEM) = Current Price: $1.81; Up 21%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.125; Up 67%
Athersys Inc. (ATHX) = Current Price: $0.87; Up 10%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.09; Unchanged
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.60; Up 2%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0086; Up 23%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.62; Up 7%
Neuralstem (CUR) = Current Price: $1.06; Up 6%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.50; Up 6%
LifeStem International (LSTM.OB) = Current Price: $0.0075; Up 15%
MultiCell Technologies (MCET.OB) = Current Price: $0.0135; Unchanged
Pluristem Therapeutics (PSTI) = Current Price: $1.35; Up 16%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.08; Unchanged
Stem Cell Innovations (SCLL.PK) = Current Price: $0.006; Down -20%

Possible Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Ending Thoughts:

My gut feeling tells me that the market will trade higher on Monday, but will slide lower the rest of the week. The quarter is coming to an end and after such thunderous gains, the market may be looking to take a breather. If this does take place, DOW 8000 becomes the new technical point of resistance. It's hard to determine where exactly this leaves the stem cell stocks, but be mindful that a pullback may occur.

Stem Cell Stocks 3/22/09: The Week That Was

As a whole, this was not a good week for the stem cell stocks. Most were down 5% - 10%. The smaller caps were hit particularly hard. It has been tough to find the stem cell stocks' place in this current market. Overall, the market is in rally mode, but these stocks just have not been a part of the run. Right now, all the large cap stocks that we track are below its price prior to our reference date of 1-23-09.

Top Stem Cell Stock Performer(s) for Last Week:

- Athersys (ATHX) = Up 41% for the week; This stock rose after it reported its 2008 year end earnings. Losses narrowed, but investors seemed to be encouraged that the company is moving ahead with its adult stem cell therapy Multistem. After spiking after the announcement on 1-23-09, ATHX dropped precipitously for a month and a half. This was the first sign of a possible reversal.

Worst Stem Cell Stock Performer(s) for Last Week:

- Advanced Cell Technology Inc. (ACTC.PK) = Down -40% for the week; There has been no news and the volume has been average. Although the drop has been substantial, there's not a lot of force behind it. Bargain hunters will probably scoop this up quickly next week.

Stem Cell Stocks Current Price and % Up or Down Since the First Rally on 1/23/09
Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.25; Down -13%
Aastrom Biosciences (ASTM) = Current Price: $0.35; Down -32%
BioTime, Inc. (BTIM) = Current Price: $2.05; Down -2%
Celgene Corp (CELG) = Current Price: $45.52; Down -7%
Cytori Therapeutics (CYTX) = Current Price: $1.72; Down -46%
Geron Corp (GERN) = Current Price: $4.08; Down -22%
ThermoGenesis (KOOL) = Current Price: $0.51; Down -6%
Osiris Therapeutics (OSIR) = Current Price: $18.04; Down -4%
StemCell Inc. (STEM) = Current Price: $1.50; Down -30%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.PK) = Current Price: $0.075; Down -38%
Athersys Inc. (ATHX) = Current Price: $0.79; Up 16%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.0925; Down -8%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.59; Down -25%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.007; Up 84%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.58; Up 26%
Neuralstem (CUR) = Current Price: $1.00; Down -30%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.47; Up 62%
LifeStem International (LSTM.OB) = Current Price: $0.0065; Up 67%
MultiCell Technologies (MCET.OB) = Current Price: $0.0135; Up 214%
Pluristem Therapeutics (PSTI) = Current Price: $1.16; Up 82%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.0925; Up 50%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.0075; Up 36%

Possible Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- Analysis upgrades are coming. These stocks are just getting too cheap.

Although the catalysts above could help cause the stem cell stocks to end their current slide, I don't think you'll see another huge move until one of the companies in the sector get's bought out or a hostile takeover is made public. Because stem cell stocks focus on research, very few if any are going to have earnings. When a stock doesn't have earnings, it is very difficult for the market to accurately assign it a value. Until M&A activity happens, don't expect any monster pops.

The main reason I do this blog and others, is so we can call make some money. You can also check out another blog I've started called "The Perfect Stock" at http://theperfectstock.blogspot.com/ . The site picks a stock covering all sectors that is perfectly setup both fundamentally and technically. Check it out when you get a chance.